FDA: Ophthalmic drugs and devices
ASCRS advocates to ensure our members and their patients have timely access to innovative drugs and devices and access to compounded medications.
ASCRS advocates to ensure our members and their patients have timely access to innovative drugs and devices and access to compounded medications.
© 2024 ASCRS. All Rights Reserved.
We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.